This letter highlights the emerging practice of employing digital clones of deceased individuals in grief care, addressing both their potential therapeutic benefits and the ethical and legal complexities they raise. While such technologies may offer novel avenues for bereavement support, there is a potential need for robust posthumous consent mechanisms and regulatory oversight to ensure respect for dignity and privacy.
Biomedicines. 2025 Apr 8;13(4):901. doi: 10.3390/biomedicines13040901.ABSTRACTBackground/Objectives: Schizophrenia and nicotine misuse are a comorbid condition that frequently develops during adolescence. Considering the role of the nucleus...
Biomedicines. 2025 Apr 8;13(4):898. doi: 10.3390/biomedicines13040898.ABSTRACTObjective: Patients with bipolar disorder (BD) may exhibit common and significant changes in brain activity across different networks. Our aim...
Biomedicines. 2025 Apr 3;13(4):866. doi: 10.3390/biomedicines13040866.ABSTRACTBackground: The purpose of the study is to investigate a possible predictive value of irisin for improved left ventricular (LV)...
Biomedicines. 2025 Mar 24;13(4):787. doi: 10.3390/biomedicines13040787.ABSTRACTBackground: Every year, over 40 million people sustain mild traumatic brain injury (mTBI) which affects the glucocorticoid stress pathway and...
Epileptic Disord. 2025 Apr 29. doi: 10.1002/epd2.70034. Online ahead of print.ABSTRACTOBJECTIVE: A global increase in the aging population has resulted in more patients with late-onset...
